Organisation · Unternehmen
ALK-Abelló A/S
alk-abell243-as-eutr-10227113
Aussagen (8)
eu transparency category
Companies & groups
dokumentiert
[Q-23308]
eu transparency goals
ALK is a Denmark-based, global specialty pharmaceutical company focused on allergy. For over a century, we have been at the forefront of long-term allergy treatment and innovation, working with passion and dedication to help people living with this chronic disease, their families and the healthcare professionals who treat them.
Allergy is a widespread, chronic disease impacting and challenging the lives of millions of adults and children globally every day. In fact, it is estimated to affect one in four people in the industrialised world.
At ALK, our purpose is to improve the lives of those living with moderate to severe allergies, by continuing to build on our rich legacy of scientific expertise and advancements. We do this by following our strategy, Allergy+, paving the way for us to achieve our goals through focus, innovation, cultivation and optimisation.
Allergy is a widespread, chronic disease impacting and challenging the lives of millions of adults and children globally every day. In fact, it is estimated to affect one in four people in the industrialised world.
At ALK, our purpose is to improve the lives of those living with moderate to severe allergies, by continuing to build on our rich legacy of scientific expertise and advancements. We do this by following our strategy, Allergy+, paving the way for us to achieve our goals through focus, innovation, cultivation and optimisation.
dokumentiert
[Q-23308]
eu transparency id
3943604102271-13
dokumentiert
[Q-7536]
headquarters city
Hørsholm
dokumentiert
[Q-23308]
headquarters country
DE
dokumentiert
[Q-23308]
interest class
business_company
dokumentiert
[Q-29773]
legal form
Corporation
dokumentiert
[Q-23308]
legal form class
ausland_sonstig
berichtet
[Q-29773]